Balentine LLC Galapagos Nv Transaction History
Balentine LLC
- $2.2 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding GLPG
# of Institutions
90Shares Held
17.4MCall Options Held
10.4KPut Options Held
33.1K-
Eco R1 Capital, LLC San Francisco, CA5.76MShares$166 Million5.04% of portfolio
-
Bvf Inc San Francisco, CA1.57MShares$45.2 Million1.19% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$40.6 Million0.73% of portfolio
-
Prosight Management, LP Dallas, TX1.35MShares$38.9 Million10.45% of portfolio
-
Segall Bryant & Hamill, LLC Chicago, IL799KShares$23 Million0.36% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.9B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...